Mirelman D - Search Results

1

Allicin stimulates lymphocytes and elicits an antitumor effect: a possible role of p21ras.

Patya M, Zahalka MA, Vanichkin A, Rabinkov A, Miron T, Mirelman D, Wilchek M, Lander HM, Novogrodsky A. Patya M, et al. Among authors: mirelman d. Int Immunol. 2004 Feb;16(2):275-81. doi: 10.1093/intimm/dxh038. Int Immunol. 2004. PMID: 14734613

2

Efficacy of allicin, the reactive molecule of garlic, in inhibiting Aspergillus spp. in vitro, and in a murine model of disseminated aspergillosis.

Shadkchan Y, Shemesh E, Mirelman D, Miron T, Rabinkov A, Wilchek M, Osherov N. Shadkchan Y, et al. Among authors: mirelman d. J Antimicrob Chemother. 2004 May;53(5):832-6. doi: 10.1093/jac/dkh174. Epub 2004 Mar 24. J Antimicrob Chemother. 2004. PMID: 15044429

3

The effects of allicin on weight in fructose-induced hyperinsulinemic, hyperlipidemic, hypertensive rats.

Elkayam A, Mirelman D, Peleg E, Wilchek M, Miron T, Rabinkov A, Oron-Herman M, Rosenthal T. Elkayam A, et al. Among authors: mirelman d. Am J Hypertens. 2003 Dec;16(12):1053-6. doi: 10.1016/j.amjhyper.2003.07.011. Am J Hypertens. 2003. PMID: 14643581

4

Inhibition of tumor growth by a novel approach: in situ allicin generation using targeted alliinase delivery.

Miron T, Mironchik M, Mirelman D, Wilchek M, Rabinkov A. Miron T, et al. Among authors: mirelman d. Mol Cancer Ther. 2003 Dec;2(12):1295-301. Mol Cancer Ther. 2003. PMID: 14707270

5

Allicin inhibits SDF-1alpha-induced T cell interactions with fibronectin and endothelial cells by down-regulating cytoskeleton rearrangement, Pyk-2 phosphorylation and VLA-4 expression.

Sela U, Ganor S, Hecht I, Brill A, Miron T, Rabinkov A, Wilchek M, Mirelman D, Lider O, Hershkoviz R. Sela U, et al. Among authors: mirelman d. Immunology. 2004 Apr;111(4):391-9. doi: 10.1111/j.0019-2805.2004.01841.x. Immunology. 2004. PMID: 15056375 Free PMC article.

6

Apoptotic killing of B-chronic lymphocytic leukemia tumor cells by allicin generated in situ using a rituximab-alliinase conjugate.

Arditti FD, Rabinkov A, Miron T, Reisner Y, Berrebi A, Wilchek M, Mirelman D. Arditti FD, et al. Among authors: mirelman d. Mol Cancer Ther. 2005 Feb;4(2):325-31. Mol Cancer Ther. 2005. PMID: 15713903

7

The effects of S-allylmercaptocaptopril, the synthetic product of allicin and captopril, on cardiovascular risk factors associated with the metabolic syndrome.

Oron-Herman M, Rosenthal T, Mirelman D, Miron T, Rabinkov A, Wilchek M, Sela BA. Oron-Herman M, et al. Among authors: mirelman d. Atherosclerosis. 2005 Dec;183(2):238-43. doi: 10.1016/j.atherosclerosis.2005.03.009. Epub 2005 Apr 14. Atherosclerosis. 2005. PMID: 16285991

8

The antiatherogenic effect of allicin: possible mode of action.

Gonen A, Harats D, Rabinkov A, Miron T, Mirelman D, Wilchek M, Weiner L, Ulman E, Levkovitz H, Ben-Shushan D, Shaish A. Gonen A, et al. Among authors: mirelman d. Pathobiology. 2005;72(6):325-34. doi: 10.1159/000091330. Pathobiology. 2005. PMID: 16582584

9

Allicin up-regulates cellular glutathione level in vascular endothelial cells.

Horev-Azaria L, Eliav S, Izigov N, Pri-Chen S, Mirelman D, Miron T, Rabinkov A, Wilchek M, Jacob-Hirsch J, Amariglio N, Savion N. Horev-Azaria L, et al. Among authors: mirelman d. Eur J Nutr. 2009 Mar;48(2):67-74. doi: 10.1007/s00394-008-0762-3. Epub 2008 Dec 1. Eur J Nutr. 2009. PMID: 19048328

10

[3H]Allicin: preparation and applications.

Miron T, Bercovici T, Rabinkov A, Wilchek M, Mirelman D. Miron T, et al. Among authors: mirelman d. Anal Biochem. 2004 Aug 15;331(2):364-9. doi: 10.1016/j.ab.2004.03.054. Anal Biochem. 2004. PMID: 15265743

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters